Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
15
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Mohideen Pharis | Chief Medical Officer | 29 | $0 | $46.3K | 2026-07-29 |
| BAKER JULIAN | Director | 4 | $0 | $0 | 2026-01-12 |
| EPIC Bpifrance | Other | 3 | $0 | $15.48M | 2025-12-18 |
| Trapp Kevin Michael | Chief Commercial Officer | 2 | $0 | $0 | 2025-11-21 |
| Boucinha Virginie | Chief Financial Officer | 6 | $0 | $0 | 2025-11-21 |
| Tasse Daniel | Chief Executive Officer | 6 | $14.2K | $0 | 2025-11-21 |
| Baker Brothers Life Sciences LP | Director, 10% Owner | 4 | $0 | $0 | 2025-03-27 |
| Ndu Adora | Director | 2 | $50.3K | $0 | 2024-02-06 |
| MORRIS TIMOTHY E | Director | 2 | $66.9K | $0 | 2023-08-25 |
| SOLAND DANIEL B | Director | 2 | $73.0K | $0 | 2023-08-01 |
| Robitaille Sebastien | Chief Financial Officer | 4 | $0 | $0 | 2022-11-21 |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | 4 | $0 | $0 | 2022-06-13 |
| Monges Viviane | Director | 1 | $35.6K | $0 | 2021-06-10 |
| Rao Madduri Ravin | Director | 1 | $48.7K | $0 | 2021-06-10 |
| DE ROSEN MICHEL | Director | 1 | $48.7K | $0 | 2021-06-10 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Mohideen Pharis | Chief Medical Officer | S Sale | 2026-07-29 | 2026-07-31 | 464 | $2.70 | $1.3K | 144,531 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2026-07-29 | 2026-07-31 | 464 | $2.70 | $1.3K | 144,531 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2026-01-29 | 2026-02-02 | 534 | $4.86 | $2.6K | 144,995 | SEC↗ |
| BAKER JULIAN | Director | M Exercise deriv | 2026-01-12 | 2026-01-14 | 2,299,656 | — | $0 | 0 | SEC↗ |
| BAKER JULIAN | Director | M Exercise deriv | 2026-01-12 | 2026-01-14 | 2,299,656 | — | $0 | 2,299,656 | SEC↗ |
| BAKER JULIAN | Director | M Exercise deriv | 2026-01-12 | 2026-01-14 | 25,005,240 | — | $0 | 0 | SEC↗ |
| BAKER JULIAN | Director | M Exercise deriv | 2026-01-12 | 2026-01-14 | 25,005,240 | — | $0 | 25,005,240 | SEC↗ |
| EPIC Bpifrance | Other | S Sale | 2025-12-18 | 2025-12-19 | 1,292,103 | $4.19 | $5.41M | 7,303,369 | SEC↗ |
| EPIC Bpifrance | Other | S Sale | 2025-12-17 | 2025-12-19 | 2,036,990 | $4.84 | $9.86M | 8,635,472 | SEC↗ |
| EPIC Bpifrance | Other | S Sale | 2025-12-17 | 2025-12-19 | 40,000 | $5.28 | $211.2K | 8,595,472 | SEC↗ |
| Tasse Daniel | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-11-21 | 2025-11-24 | 964,000 | — | $0 | 964,000 | SEC↗ |
| Trapp Kevin Michael | Chief Commercial Officer | A Award deriv | 2025-11-21 | 2025-11-24 | 316,250 | — | $0 | 316,250 | SEC↗ |
| Boucinha Virginie | Chief Financial Officer | A Award deriv | 2025-11-21 | 2025-11-24 | 192,000 | — | $0 | 192,000 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | A Award deriv | 2025-11-21 | 2025-11-25 | 253,000 | — | $0 | 253,000 | SEC↗ |
| Trapp Kevin Michael | Chief Commercial Officer | A Award | 2025-11-21 | 2025-11-24 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Boucinha Virginie | Chief Financial Officer | A Award | 2025-11-21 | 2025-11-24 | 32,000 | — | $0 | 70,000 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | A Award | 2025-11-21 | 2025-11-25 | 44,000 | — | $0 | 145,529 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2025-11-21 | 2025-11-25 | 1,624 | $2.77 | $4.5K | 101,529 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2025-11-20 | 2025-11-25 | 6,496 | $2.88 | $18.7K | 103,153 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2025-07-29 | 2025-07-31 | 464 | $2.22 | $1.0K | 109,649 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2025-05-22 | 2025-05-27 | 397 | $1.84 | $730 | 110,113 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | A Award deriv | 2025-03-27 | 2025-03-31 | 25,005,240 | — | $0 | 25,005,240 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | A Award deriv | 2025-03-27 | 2025-03-31 | 25,005,240 | — | $0 | 25,005,240 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | A Award deriv | 2025-03-27 | 2025-03-31 | 2,299,656 | — | $0 | 2,299,656 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | A Award deriv | 2025-03-27 | 2025-03-31 | 2,299,656 | — | $0 | 2,299,656 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2025-01-30 | 2025-01-31 | 600 | $0.85 | $510 | 110,510 | SEC↗ |
| Tasse Daniel | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-12-04 | 2024-12-05 | 813,200 | — | $0 | 813,200 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2024-11-25 | 2024-11-27 | 565 | $0.57 | $322 | 111,110 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2024-11-22 | 2024-11-27 | 342 | $0.53 | $181 | 111,675 | SEC↗ |
| Boucinha Virginie | Chief Financial Officer | A Award deriv | 2024-11-21 | 2024-11-25 | 113,000 | — | $0 | 113,000 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | A Award deriv | 2024-11-21 | 2024-11-25 | 215,000 | — | $0 | 215,000 | SEC↗ |
| Boucinha Virginie | Chief Financial Officer | A Award | 2024-11-21 | 2024-11-25 | 19,000 | — | $0 | 38,000 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2024-11-21 | 2024-11-25 | 2,350 | $0.54 | $1.3K | 112,017 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | A Award | 2024-11-21 | 2024-11-25 | 35,000 | — | $0 | 114,367 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2024-07-29 | 2024-07-31 | 1,785 | $0.98 | $1.7K | 79,367 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2024-05-24 | 2024-05-29 | 660 | $1.36 | $898 | 81,152 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2024-05-22 | 2024-05-29 | 382 | $1.38 | $527 | 81,812 | SEC↗ |
| Tasse Daniel | CHIEF EXECUTIVE OFFICER | P Buy | 2024-03-08 | 2024-03-11 | 17,094 | $0.83 | $14.2K | 17,094 | SEC↗ |
| Ndu Adora | Director | P Buy | 2024-02-06 | 2024-02-08 | 1,825 | $0.89 | $1.6K | 1,825 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2023-11-22 | 2023-12-19 | 2,245 | $1.74 | $3.9K | 82,194 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | A Award deriv | 2023-11-20 | 2023-11-22 | 215,000 | — | $0 | 215,000 | SEC↗ |
| Tasse Daniel | Chief Executive Officer | A Award deriv | 2023-11-20 | 2023-11-22 | 806,672 | — | $0 | 806,672 | SEC↗ |
| Boucinha Virginie | Chief Financial Officer | A Award deriv | 2023-11-20 | 2023-11-22 | 113,000 | — | $0 | 113,000 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | A Award | 2023-11-20 | 2023-11-22 | 35,000 | — | $0 | 84,439 | SEC↗ |
| Boucinha Virginie | Chief Financial Officer | A Award | 2023-11-20 | 2023-11-22 | 19,000 | — | $0 | 19,000 | SEC↗ |
| MORRIS TIMOTHY E | Director | P Buy | 2023-08-25 | 2023-08-28 | 12,000 | $1.52 | $18.2K | 12,000 | SEC↗ |
| SOLAND DANIEL B | Director | P Buy | 2023-08-01 | 2023-08-03 | 15,000 | $1.62 | $24.3K | 20,000 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2023-05-24 | 2023-08-14 | 469 | $3.54 | $1.7K | 49,439 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | S Sale | 2022-11-24 | 2023-08-14 | 1,792 | $2.88 | $5.2K | 49,908 | SEC↗ |
| Robitaille Sebastien | Chief Financial Officer | A Award deriv | 2022-11-21 | 2023-08-14 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | A Award deriv | 2022-11-21 | 2023-08-14 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Tasse Daniel | Chief Executive Officer | A Award deriv | 2022-11-21 | 2023-08-14 | 764,386 | — | $0 | 764,386 | SEC↗ |
| Robitaille Sebastien | Chief Financial Officer | A Award | 2022-11-21 | 2023-08-14 | 8,000 | — | $0 | 36,500 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | A Award | 2022-11-21 | 2023-08-14 | 17,500 | — | $0 | 51,700 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | A Award deriv | 2022-07-29 | 2023-08-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | A Award | 2022-07-29 | 2023-08-14 | 10,000 | — | $0 | 34,200 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | A Award deriv | 2022-06-13 | 2022-06-13 | 11,732,979 | — | $0 | 11,732,979 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | A Award deriv | 2022-06-13 | 2022-06-13 | 1,383,352 | — | $0 | 1,383,352 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | A Award | 2022-06-13 | 2022-06-13 | 1,252,432 | — | $0 | 1,585,054 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | A Award | 2022-06-13 | 2022-06-13 | 10,622,568 | — | $0 | 14,575,984 | SEC↗ |
| Robitaille Sebastien | Chief Financial Officer | A Award deriv | 2021-11-22 | 2021-11-24 | 51,000 | — | $0 | 51,000 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | A Award deriv | 2021-11-22 | 2021-11-24 | 95,400 | — | $0 | 95,400 | SEC↗ |
| Tasse Daniel | Chief Executive Officer | A Award deriv | 2021-11-22 | 2021-11-24 | 274,000 | — | $0 | 274,000 | SEC↗ |
| Robitaille Sebastien | Chief Financial Officer | A Award | 2021-11-22 | 2021-11-24 | 5,000 | — | $0 | 28,500 | SEC↗ |
| Mohideen Pharis | Chief Medical Officer | A Award | 2021-11-22 | 2021-11-24 | 8,700 | — | $0 | 24,200 | SEC↗ |
| Rao Madduri Ravin | Director | P Buy deriv | 2021-06-10 | 2021-06-11 | 6,837 | $7.12 | $48.7K | 6,837 | SEC↗ |
| DE ROSEN MICHEL | Director | P Buy deriv | 2021-06-10 | 2021-06-11 | 6,837 | $7.12 | $48.7K | 6,837 | SEC↗ |
| Monges Viviane | Director | P Buy deriv | 2021-06-10 | 2021-06-11 | 5,000 | $7.12 | $35.6K | 5,000 | SEC↗ |
| MORRIS TIMOTHY E | Director | P Buy deriv | 2021-06-10 | 2021-06-11 | 6,837 | $7.12 | $48.7K | 6,837 | SEC↗ |
| Ndu Adora | Director | P Buy deriv | 2021-06-10 | 2021-06-11 | 6,837 | $7.12 | $48.7K | 6,837 | SEC↗ |
| SOLAND DANIEL B | Director | P Buy deriv | 2021-06-10 | 2021-06-11 | 6,837 | $7.12 | $48.7K | 6,837 | SEC↗ |